Maralixibat 9.5 mg/ML [Livmarli]
RxNorm 2571081

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2571081 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: maralixibat 9.5 mg/ML [Livmarli].

The following semantic concepts and normalized strings are associated with this clinical entity:

SBDC
Maralixibat 9.5 mg/ML [Livmarli]
AUI:12687844
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBDCPrescribable

Semantic Branded Drug Component (SBDC):
Maralixibat 9.5 mg/ML [Livmarli]
(Atom ID: 12687844)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
maralixibat 9.5 MG/ML [Livmarli]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2571081
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12687844
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBDC
Semantic Branded Drug Component (Ingredient + Strength + Brand Name)
Source Code
2571081
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Maralixibat


Maralixibat is used to treat itching caused by Alagille syndrome (ALGS, an inherited condition in which bile builds up in the liver and causes liver damage) in adults and children 1 year of age or older. Maralixibat is in a class of medications called ileal bile acid transporter inhibitors. It works by decreasing the amount of bile acids in the body.
[Learn More]


* Please review the disclaimer below.